Online citations, reference lists, and bibliographies.
← Back to Search

Preparation And Characterization Of Solid Lipid Nanoparticles Containing Cyclosporine By The Emulsification-diffusion Method

Z. Urbán-Morlán, A. Ganem-Rondero, L. M. Melgoza-Contreras, José Juan Escobar-Chávez, M. G. Nava-Arzaluz, D. Quintanar-Guerrero
Published 2010 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Solid lipid nanoparticles (SLNs) have been used for carrying different therapeutic agents because they improve absorption and bioavailability. The aim of the study was to prepare lipidic nanoparticles containing cyclosporine (CyA) by the emulsification-diffusion method and to study their physicochemical stability. Glyceryl behenate (Compritol® ATO 888) and lauroyl macrogolglycerides (Gelucire® 44/14) were used as carrier materials. Nanoparticles with good stability were obtained with Gelucire®, while it was difficult to obtain stable systems with Compritol®. Systems with Gelucire® were characterized by particle size, Z-potential, differential scanning calorimetry (DSC), scanning electron microscopy (SEM), entrapment efficiency and in vitro release. Particle size and Z-potential were evaluated for at least three months. With a high CyA content (≥60 mg) in Gelucire® SLNs, variations in size were greater and particle size also increased over time in all batches; this effect may have been caused by a probable expulsion of the drug due to the lipid’s partial rearrangement. While the Z-potential decreased 10 mV after three months, this effect may be explained by the superficial properties of the drug that make the molecules to be preferably oriented at the solid-liquid interface, causing a change in the net charge of the particle. SEM confirmed size and shape of the nanoparticles. DSC studies evidenced that CyA affects the lipid structure by a mechanism still unknown. The entrapment efficiency was higher than 92%, and CyA release from SLNs was relatively fast (99.60% in 45 min).
This paper references
10.1023/A:1015843517762
Enhanced Intestinal Absorption of Cyclosporine in Rats Through the Reduction of Emulsion Droplet Size
B. Tarr (2004)
10.1016/J.JCONREL.2006.05.010
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
Yifan Luo (2006)
10.3109/08982100903161456
Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles
J. Varshosaz (2010)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
10.1016/S0142-9612(03)00331-4
Physico-chemical stability of colloidal lipid particles.
B. Heurtault (2003)
10.1016/J.IJPHARM.2004.11.010
Preparation and characterization of triclosan nanoparticles for periodontal treatment.
E. Piñón-Segundo (2005)
Urbán-Morlán et al
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process : purification of an injectable dosage form
E. Allémann (1993)
10.1016/J.TCA.2006.05.007
Influence of the leprosy drug, dapsone on the model membrane dipalmitoyl phosphatidylethanolamine
L. Panicker (2006)
10.3109/03639040903241817
Electrospray technique for solid lipid-based particle production
M. Trotta (2010)
10.1016/0378-5173(93)90369-Q
Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A
A. Sánchez (1993)
10.1016/0378-5173(94)00243-X
Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporin
A. Al-Angary (1995)
10.1002/JPS.2600820513
Formation and characterization of cyclosporine-loaded nanoparticles.
M. Guzmán (1993)
10.1016/J.ADDR.2007.04.005
Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.
A. Hanafy (2007)
10.1016/j.ijpharm.2009.10.020
Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration.
A. del Pozo-Rodríguez (2010)
10.2174/156720108783331069
Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
Jigisha K Varia (2008)
Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovidine
S Singh (2010)
Preparación de dispersiones lipídicas de talla submicrónica por medio del método de emulsificación difusión
D Tamayo-Esquivel (2005)
Eur J Pharm Biopharm
(2008)
10.1016/J.JCONREL.2005.06.006
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
K. Manjunath (2005)
10.1002/JPS.2600830336
Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation.
J. Kovarik (1994)
10.1166/JNN.2006.474
Evaluation of the enhanced oral effect of omapatrilat-monolein nanoparticles prepared by the emulsification-diffusion method.
D. Tamayo-Esquivel (2006)
10.1016/S0040-6031(02)00074-6
The interaction of a peptide with a scrambled hydrophobic/hydrophilic sequence (Pro-Asp-Ala-Asp-Ala-His-Ala-His-Ala-His-Ala-Ala-Ala-His-Gly) (PADH) with DPPC model membranes: a DSC study
D. Grasso (2002)
10.1016/J.EJPS.2005.06.001
Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres.
D. Quintanar-Guerrero (2005)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/J.JBIOTEC.2004.06.007
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
R. H. Muller (2004)
10.1248/CPB.58.650
Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine.
S. Singh (2010)
Powered by TCPDF (www.tcpdf.org)
Preparación de dispersiones lipídicas de talla submicrónica por medio del método de emulsificación difusión , Tesis de Maestría , Universidad Nacional Autónoma de México
E Allemann (2005)
10.1016/J.EJPB.2007.07.006
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
R. Mueller (2008)
10.1021/JS950164R
Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement.
J. Molpeceres (1996)
Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
L. Hu (2010)
10.3109/02652040903031279
Solid lipid nanoparticles produced through a coacervation method
L. Battaglia (2010)
10.1016/S0378-5173(02)00180-1
Nanostructured lipid matrices for improved microencapsulation of drugs.
R. Mueller (2002)
10.1016/j.ijpharm.2008.07.028
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
E. Gokce (2008)
10.1002/JPS.10444
Properties and stability of a liquid crystal form of cyclosporine-the first reported naturally occurring peptide that exists as a thermotropic liquid crystal.
D. Lechuga-Ballesteros (2003)
10.1016/J.IJPHARM.2006.07.026
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
N. Zhang (2006)
10.1007/S003960050130
A mechanistic study of the formation of polymer nanoparticles by the emulsification-diffusion technique
D. Quintanar-Guerrero (1997)



This paper is referenced by
10.1016/J.JDDST.2018.05.032
Novel drug delivery systems based on the encapsulation of superparamagnetic nanoparticles into lipid nanocomposites
Edith Estefany Delgado-Rosales (2018)
RECENT ADVANCES BASED ON SOLID LIPID NANOPARTICLE SYSTEMS FOR DELIVERY OF DRUGS
P. Dhanalakshmi (2012)
10.1002/9781118773826.CH6
Functional Nanomaterials for Multifarious Nanomedicine
R. Singh (2014)
10.1016/j.jconrel.2018.07.036
A bird's eye view of nanoparticles prepared by electrospraying: advancements in drug delivery field
Abhijit J. Pawar (2018)
10.1111/jphp.12947
Improvement in dissolution rate and photodynamic efficacy of chlorin e6 by sucrose esters as drug carrier in nanosuspension formulation: optimisation and in vitro characterisation
S. Paul (2018)
10.1016/j.matpr.2020.04.109
Solid lipid nanoparticles for oral drug delivery
S. K. Basha (2020)
10.1007/978-1-4939-1289-6
Topical Drug Bioavailability, Bioequivalence, and Penetration
V. Shah (2014)
10.1016/j.micron.2012.07.008
Electron microscopy of pharmaceutical systems.
V. Klang (2013)
10.5897/AJPPX12.001
Novel topical drug carriers as a tool for treatment of psoriasis: Progress and advances
P. Suresh (2013)
10.1080/10717544.2016.1272651
Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration
Fakhar ud Din (2017)
10.1016/J.JTICE.2014.08.035
Carmustine-loaded catanionic solid lipid nanoparticles with serotonergic 1B receptor subtype antagonist for in vitro targeted delivery to inhibit brain cancer growth
Y. Kuo (2015)
10.3109/03639045.2015.1038274
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility
M. Durán-Lobato (2016)
10.1016/J.COLSURFA.2016.05.017
Rapamycin-loaded solid lipid nanoparticles: Morphology and impact of the drug loading on the phase transition between lipid polymorphs
J. Mazuryk (2016)
A REVIEW ON NANOTECHNOLOGY IN SOLID LIPID NANOPARTICLES
I. Sarathchandiran (2012)
10.1007/978-1-4939-1289-6_12
Development of Pilosebaceous Unit-Targeted Drug Products
G. W. Lu (2014)
10.1016/j.ijpharm.2018.02.038
Lipid-based nanosuspensions for oral delivery of peptides, a critical review.
Camille Dumont (2018)
10.1016/j.ijpharm.2017.09.017
Designing lipid nanoparticles for topical ocular drug delivery.
J. Álvarez-Trabado (2017)
10.4018/978-1-7998-1518-1.ch006
Optimizing the Size of Drug-Loaded Nanoparticles Using Design of Experiments: Solid Lipid Nanoparticles
Paola Cervantes-Covarrubias (2020)
10.1016/j.jcis.2017.06.022
Single-component solid lipid nanocarriers prepared with ultra-long chain amphiphilic lipids.
W. Wei (2017)
10.2147/IJN.S215153
Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution
Ji-Hyun Kang (2019)
Recent trends in application of nanotechnology in food processing.
Sharanakumar Hiregoudar (2011)
10.1007/s00018-019-03317-9
Nanoscale delivery systems for microRNAs in cancer therapy
Sanda C Boca (2019)
10.1002/9781118523025.CH7
Utility and Potential Application of Nanomaterials in Medicine
R. Singh (2012)
10.1016/J.JDDST.2018.10.003
Nanostructured lipid carriers containing Amphotericin B: Development, in vitro release assay, and storage stability
R. R. Santiago (2018)
10.1007/S12247-020-09494-6
Development and Characterization of Starch/Gelatin Microneedle Arrays Loaded with Lecithin–Gelatin Nanoparticles of Losartan for Transdermal Delivery
Ramón Andrés Pineda-Álvarez (2020)
10.4155/tde.15.23
The use of solid lipid nanoparticles for sustained drug release.
A. Attama (2015)
10.1016/B978-0-12-800091-5.00003-3
Chapter Three - Electron Microscopy of Pharmaceutical Systems
V. Klang (2014)
10.1007/978-3-319-41421-8_14
Drug Delivery by Polymer Nanoparticles: The Challenge of Controlled Release and Evaluation
C. Charrueau (2016)
10.1080/10837450.2018.1550789
Influence of protamine shell on nanoemulsions as a carrier for cyclosporine-A skin delivery
M. J. Alvarez-Figueroa (2019)
10.1039/C5GC00695C
Biocatalytic synthesis of ultra-long-chain fatty acid sugar alcohol monoesters
W. Wei (2015)
10.1590/S1516-89132013005000011
Nanoparticle-based drug delivery systems: promising approaches against infections
Shweta Ranghar (2013)
ON NANOTECHNOLOGY IN SOLID LIPID NANOPARTICLES
I. Sarathchandiran (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar